Genespire
PrivateLast Round
Series B
Sep 25, 2024
Total Funding Raised
$69.39M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Genespire is a biotechnology company that develops off-the-shelf gene therapies for pediatric patients affected by genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genespire Comparables
Compare Genespire with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iECURE | 81% | |
| Eli Lilly and Company | 78% | |
| Vivet Therapeutics | 77% | |
Genespire Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 25, 2024 | ||||
| Series A | Apr 29, 2020 |
Genespire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XGEN Venture | Series B |
| Indaco Venture Partners SGR | Series B |
| CDP Venture Capital SGR | Series B |
| Sofinnova Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 286% MoM, from 317 to 1.2K.
- Apr 4, 2026
Monthly visitors increased 54% MoM.
Genespire Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genespire's valuation, stock price, and market status.